Open Access

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - CON.

Congress Presentation

About the speaker

Assistant Professor Evangelos Giannitsis

University hospital Heidelberg, Heidelberg (Germany)
17 presentations
3 followers

5 more presentations in this session

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - PRO.

Speaker: Professor C. Mueller (Basel, CH)

Thumbnail

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - Discussion.

Thumbnail

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – PRO.

Speaker: Professor R. Lopes (Durham, US)

Thumbnail

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – CON.

Speaker: Professor G. Montalescot (Paris, FR)

Thumbnail

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – Discussion.

Thumbnail

Access the full session

The 2020 NSTE - ACS guidelines in practice – the pros and cons

Speakers: Assistant Professor E. Giannitsis, Professor C. Mueller, Professor R. Lopes, Professor G. Montalescot
Thumbnail

About the event

Image

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Related content

ESC Premium Access

What's next to reduce cardiovascular risk? - Chat Moderator.

27 August 2021

ESC Premium Access

Lipoprotein(a) and cardiovascular risk.

27 August 2021

ESC Premium Access

BIC-8 Revisited - Copeptin together with high sensitivity troponin for managemnent of suspected NSTE-ACS

27 August 2021

ESC 365 is supported by

logo Novo Nordisk